Revelation Biosciences, Inc. (REVBW) stock

REVBWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVB

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 6/30

$0.01+0.00 (0.00%)

Close on Oct 30, 2026Market cap $16.05MP/E –Yield –

Revelation Biosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Revelation Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.